In the Multiphasic Health Check-up System, medical laboratory testing has been changing lately to utilize a small and compact type of testing systems. The system uses heparinized blood for chemistry tests to reduce laboratory's workload and sample volume. The danaparoid, a mixture of glycosamino-glycans (Heparan sulfate), has been used clinically for treatment of patients with disseminated intravascular coagulopathy instead of heparin sulfate. Heparin has been used for routine laboratory tests, although it has a strong activity of platelet aggregation. This study aimed to examine availability of Danaparoid for routine hematology tests as a substitute of heparin. Although Danaparoid induced platelet aggregation directly, the reaction was weaker than that of heparin. The platelet count of Danaparoid blood was decreased after five minutes of mixing. Addition of MgSO4 or of kanamycin sulfate to Danaparoid blood was able to prevent this decrease. When Danaparoid blood was applied to chemistry tests, major chemistry test data showed acceptable results, although level differences were observed slightly. It was concluded that Danaparoid would be a good candidate for a universal anticoagulant for both chemical and hematological laboratory tests.
INTRODUCTION
In the Multiphasic Health Check-up System, medical laboratory testing has been changing lately to utilize a small and compact type of testing systems. The system uses heparinized blood for chemistry tests to reduce laboratory's workload and sample volume.
On the other hand, Danaparoid is a mixture of glycosaminoglycans from the intestinal mucosa of swine, which consist of heparan sulfate (84%), dermatan sulfate (12%) and chondroitin sulfate (4%). [1] It is clinically used for patients with deep vein thrombosis [2] and disseminated intravascular coagulation (DIC).131
Danaparoid is also known to have potent anticoagulant activity similar to that of heparin, [4] , [5] although platelet aggregation was in some cases observed in blood with heparin [6] - [8] due to unclarified mechanism.
Fortunately, it was reported that Danaparoid also enhanced platelet aggregation, but that its extent was lesser than that of heparin. [9] Danaparoid would be then a promising antico- control. [8] PRP was pre-incubated for one minute in the incubating hole of the aggregometer. Automated blood counting Heparin (22.5 U) or Danaparoid (22.5 U) was placed in plastic test tubes as an anticoagulant, and 1 mL of whole blood was added to the tubes in duplicate. The blood was analyzed with a NE-8000 automatic blood counter (Sysmex Co. Ltd., Kobe, Japan) immediately after blood collection (0 hours). One of the duplicate tubes was kept still for two hours and analyzed, while the other was mixed for five minutes (inverted 20 times/minute) and then analyzed. Blood anti-coagulated with EDTA-3K was used as a control. As an inhibitor of platelet aggregation, 10 
RESULTS

Platelet aggregation
When Danaparoid or heparin was added to citrated PRP, mild platelet aggregation was observed (Fig. 2) , which increased in a dose-dependent manner. However, this effect of Danaparoid was weaker than that of heparin, suggesting that physiological polysaccharides might have stimulatory effects on platelets.
Counting of hematological items
Platelet counts of blood treated with Danaparoid or heparin were lower than those of blood treated with EDTA-3K (Fig. 3) . and non-mixed specimens in this count (Fig. 4) . No difference change in red blood cell count was observed with or without mixing (Fig. 5) .
Correlation of platelet counts
The correlation coefficient for blood platelet count was over 0.9 between EDTA-3K blood and heparin or Danaparoid blood without mixing (Fig. 6) . After five minutes of mixing, the degree of correlation was decreased because of decrease in platelet count due to partial aggregation of platelets. Addition of MgSO4 or kanamycin sulfate prior to mixing was enable to prevent the platelet aggregation resulting in keeping the high correlation coefficient over 0.9.
Analysis of biochemical test results
Compared with heparin, Danaparoid blood showed slight decreases in total protein and albumin concentration ( Table 1) .
Addition of MgSO4 cannot prevent the decreases in total protein Table 1 Major blood chemistry parameters for specimens anticoagulated with Danaparoid.
All measurements were performed using dry-chemistry-based chemo-strips (Arkray Co.) The value is shown as Mean±Standard Deviation (+values are correlated by mixture and dilution factors). N=9. (*) : significant difference at p<0.05. ULL: under lower limit. The same sample was measured with different anticoagulants.
ing promises stable and reliable tests. One of disadvantageous points of the wet chemistry is requires much volume of blood for laboratory testing, and many of laboratories then have been changing their testing system from the wet one to dry-chemistry one using heparinized blood. Recently the use of Danaparoid has been popular even in the routine laboratory. For simultaneous determination of both chemistry and hematology with a minimum amount of blood, Danaparoid would be more desirable than heparin.
We confirmed that another kind of dry-chemistry-based chemistrip tests, Ektachem (Kodak), demonstrated good data to
Danaparoid blood close to those of heparin blood, although the number to be tested was only 2 cases. Thus, the results showed in Table 1 might be due to the specific matrix effects on the chemistrip we used.
In conclusion, Danaparoid would be applicable to automated hematological tests as a substitute of heparin blood, if platelet count is not needed. Regarding chemistry tests, re-calibration or value assignment measures, and further studies would be required.
